Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States
2003
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.
1998
Printed educational materials: effects on professional practice and health care outcomes
2008 Standout
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
2002
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 Standout
IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1
1998
National Institutes of Health Center for Human Immunology Conference, September 2009
2010
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Choosing an equivalence limit for noninferiority or equivalence studies
2002
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
2008 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
2002 Standout
Osteoporosis: now and the future
2011 Standout
Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial
1998
The Role of Meta-analysis in the Regulatory Process for Foods, Drugs, and Devices
1999
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Breast Cancer Metastasis
2013
Platelet Activation and Atherothrombosis
2007 Standout
Pros and cons of permutation tests in clinical trials
2000
Chemotherapy and the war on cancer
2005 Standout
Caspase Functions in Cell Death and Disease
2013 Standout
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
Systemic amyloidosis
2015 Standout
Possible aerosol transmission of COVID-19 associated with an outbreak in an apartment in Seoul, South Korea, 2020
2020
Threats to the Validity of Clinical Trials Employing Enrichment Strategies for Sample Selection
1998
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
2000 Standout
The ChEMBL database in 2017
2016 Standout
The Inflammasomes
2010 Standout
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
2009
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
2006
Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma Cells
1997 Standout
Design of Treatment Trials for Functional Gastrointestinal Disorders
2016
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
2009
Selenium in Cancer Prevention: Clinical Issues and Implications
2001
Moving from Basic Toward Systems Pharmacodynamic Models
2013
Analyzing nested experimental designs—A user-friendly resampling method to determine experimental significance
2022 StandoutNobel
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Industry sponsorship and research outcome
2012 Standout
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
2000 Standout
Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues
2000
The Physicians' Desk Reference
1996
The Fluid Dynamics of Disease Transmission
2020
Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy
1995
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999
2001
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
A Decade of Controversy: Balancing Policy With Evidence in the Regulation of Prescription Drug Advertising
2009 Standout
Value in Healthcare Initiative
2020
Approaches to the development and marketing approval of drugs that prevent cancer.
1995
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Design of Treatment Trials for Functional Gastrointestinal Disorders
2006
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
The National Cancer Institute: cancer drug discovery and development program.
1992
Airborne transmission of respiratory viruses
2021 StandoutScience
Industry sponsorship and research outcome
2017 Standout
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance?
2002
Works of Robert J. Temple being referenced
Two metres or one: what is the evidence for physical distancing in covid-19?
2020
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development
1992
Understanding comparisons of drug introductions between the united states and the united kingdom
1989
Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs
2018
Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
1992
Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
1992
New FDA Regulation to Improve Safety Reporting in Clinical Trials
2011
When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?
1997
Therapeutic-Class Wars -- Drug Promotion in a Competitive Marketplace
1994
Guidance for development of chemopreventive agents
1994
Special study designs: early escape, enrichment, studies in non-responders
1994
Study Designs in Osteoporosis
2003
The Regulatory Evolution of the Integrated Safety Summary
1991